Position history for RA CAPITAL MANAGEMENT, L.P.'s holdings in BIOCRYST PHARMACEUTICALS INC
RA CAPITAL MANAGEMENT, L.P. holds 15.8M shares of BCRX (BIOCRYST PHARMACEUTICALS INC), worth $150.7M as of 2026-Q1. BCRX represents 1.6% of RA CAPITAL MANAGEMENT, L.P.'s portfolio.
Current Value
$150.7M
Current Shares
15.8M
Total Value Change
+$27.2M
Total Shares Change
0
Other major holders of BCRX: UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC, BNP PARIBAS FINANCIAL MARKETS
Unchanged |
| 15.8M |
0.0% |
| $150.7M |
| 1.6% |
| $8.69 |
0 |
| 2025-Q4 | New | 15.8M | - | $123.5M | 1.3% | $7.66 | 69 |